Literature DB >> 6938729

Osteosarcoma of the maxilla treated with radiation therapy and surgery.

N Akbiyik, L L Alexander.   

Abstract

Osteosarcoma (osteogenic sarcoma) presumably arises from mesenchyme and is characterized by the production of malignant osteoid by the sarcomatous stroma. When all cases are considered, osteosarcoma occurs more frequently in the younger age group (peak range of 10 to 25 years of age) and commonly involves extremity bones, particularly the lower. Osteogenic sarcoma rarely arises in the maxilla. The usual treatment is radical maxillectomy, postoperative radiation therapy, and chemotherapy. Results usually are very poor.A case is presented of a 33-year-old man in whom a diagnosis of osteogenic sarcoma of the maxilla was made eight years previously. The treatment was unusual. Preoperative radiation therapy was accomplished by drilling holes in the tumor and adjacent maxilla into which were implanted high-dose radium needles. This was followed by a left radical maxillectomy. The patient is cured and is without functional deficiencies up to the present time.

Entities:  

Mesh:

Year:  1981        PMID: 6938729      PMCID: PMC2552645     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  3 in total

1.  Occupational and Post-Traumatic Cancer.

Authors:  F W Stewart
Journal:  Bull N Y Acad Med       Date:  1947-03

2.  Osteogenic sarcoma of the mandible: current management.

Authors:  R G Chambers; W D Mahoney
Journal:  Am Surg       Date:  1970-08       Impact factor: 0.688

3.  Osteogenic sarcoma of the maxilla.

Authors:  V A LiVolsi
Journal:  Arch Otolaryngol       Date:  1977-08
  3 in total
  2 in total

1.  Multimodal treatment of craniofacial osteosarcoma with high-grade histology. A single-center experience over 35 years.

Authors:  Marton König; Terje A Osnes; Ingvild Lobmaier; Bodil Bjerkehagen; Øyvind S Bruland; Kirsten Sundby Hall; Torstein R Meling
Journal:  Neurosurg Rev       Date:  2016-11-17       Impact factor: 3.042

Review 2.  Sarcomas of the head and neck.

Authors:  Dennis H Kraus
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.